ORIBIOTECH LTD
Get an alert when ORIBIOTECH LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.5m
-80.3% lowest in 3 filed years
Net assets
£7.2m
-69% lowest in 3 filed years
Employees
70
+9.4% highest in 3 filed years
Profit before tax
-£18m
+18.1% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The Directors consider it necessary to highlight the uncertainty of reaching the milestones required to receive the remaining £2.0 million of convertible loan notes, and the uncertainty and timing of a Series C fundraising. These represent material uncertainties that may cast significant doubt
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £106,000 | £474,000 | £1,065,000 | +124.7% | |
| Operating profit | -£22,481,000 | -£23,229,000 | -£18,268,000 | +21.4% | |
| Profit before tax | -£20,946,000 | -£22,173,000 | -£18,152,000 | +18.1% | |
| Net profit | -£16,667,000 | -£19,330,000 | -£16,215,000 | +16.1% | |
| Cash | £35,148,000 | £12,833,000 | £2,530,000 | -80.3% | |
| Total assets less current liabilities | — | £23,222,000 | £13,281,000 | -42.8% | |
| Net assets | £41,843,000 | £23,222,000 | £7,192,000 | -69% | |
| Equity | £41,843,000 | £23,222,000 | £7,192,000 | -69% | |
| Average employees | 59 | 64 | 70 | +9.4% | |
| Wages | £6,056,000 | £6,763,000 | £6,001,000 | -11.3% | |
| Directors' remuneration | £695,000 | £687,000 | £653,000 | -4.9% | |
| Directors' pension contributions | £17,000 | £22,000 | £23,000 | +4.5% | |
| Highest paid director | £271,000 | £359,000 | £330,000 | -8.1% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | -100.0% | -137.5% | |
| Gearing (liabilities / total assets) | 6.1% | 9.4% | 53.1% | |
| Current ratio | 15.94x | 0.93x | 3.91x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The Directors consider it necessary to highlight the uncertainty of reaching the milestones required to receive the remaining £2.0 million of convertible loan notes, and the uncertainty and timing of a Series C fundraising. These represent material uncertainties that may cast significant doubt”
Group structure
- ORIBIOTECH LTD · parent
- Ori Biotech North America Inc 100%
Significant events
- “Subsequent to the year end, a second tranche of convertible loan notes was issued to investors for a total of £3.1 million.”
- “In September 2025, the Company entered into a new lease for lab and office space.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ANDERSEN, Henrik | Director | 2026-04-10 | May 1969 | Danish |
| FOSTER, Jason Charles | Director | 2019-07-29 | Dec 1974 | American |
| HAY, Jonathan Russell | Director | 2020-08-21 | Sep 1961 | British,American |
| HUNT, Anthony | Director | 2026-04-10 | Mar 1964 | American |
| JACKSON, Andrea Liapis | Director | 2024-02-01 | Dec 1978 | American |
| JENKINS, Annalisa Mary, Dr | Director | 2021-06-30 | Jun 1965 | British |
| MEISTER, Paul Matthew | Director | 2021-12-23 | Oct 1952 | American |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARGE, Alan John, Dr | Director | 2019-07-29 | 2020-08-21 |
| CLARE, Barry | Director | 2019-07-29 | 2026-01-09 |
| KEDAR, Sharon | Director | 2020-08-21 | 2020-09-22 |
| MASON, Christopher, Professor | Director | 2019-07-29 | 2026-01-09 |
| MASON, Christopher | Director | 2015-09-02 | 2018-01-15 |
| SOCHA, Pierre Robert | Director | 2019-07-29 | 2021-12-23 |
| TRACEY, William Patrick | Director | 2018-03-26 | 2020-08-21 |
| VERAITCH, Farlan Singh | Director | 2015-09-02 | 2026-01-09 |
| WIESCHHAUS, Adam Joseph | Director | 2020-09-22 | 2024-02-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Farlan Singh Veraitch | Individual | Shares 25–50% | 2016-09-01 | Ceased 2019-08-20 |
Filing timeline
Last 20 of 113 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-01-15 MA Memorandum articles
- 2026-01-15 RESOLUTIONS Resolution
- 2025-11-21 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-16 | SH01 | capital | Capital allotment shares | |
| 2026-09-16 | AA | accounts | Accounts with accounts type group | |
| 2026-09-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-08-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-07-31 | SH01 | capital | Capital allotment shares | |
| 2026-07-31 | SH01 | capital | Capital allotment shares | |
| 2026-07-27 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-06-23 | SH01 | capital | Capital allotment shares | |
| 2026-06-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-17 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-12 | SH01 | capital | Capital allotment shares | |
| 2026-01-30 | SH10 | capital | Capital variation of rights attached to shares | |
| 2026-01-30 | SH08 | capital | Capital name of class of shares | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-15 | MA | incorporation | Memorandum articles | |
| 2026-01-15 | RESOLUTIONS | resolution | Resolution | |
| 2025-11-21 | RESOLUTIONS | resolution | Resolution | |
| 2025-11-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 20
- Capital events
- 7
- Officers appointed
- 2
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.